PURPOSE: We aimed to evaluate the utility of cardiac magnetic resonance imaging (MRI) for the diagnosis of infective endocarditis (IE). METHODS: Sixteen patients with a preliminary diagnosis of IE (10 women and six men; age range, 4-66 years) were referred for cardiac MRI. MRI sequences were as follows: echo-planar cine true fast imaging with steady-state precession (true-FISP), dark-blood fast spin echo T1-weighted imaging, T2-weighted imaging, dark-blood half-Fourier single shot turbo spin echo (HASTE), and early contrast-enhanced first-pass fast low-angle shot (FLASH). Delayed contrast-enhanced images were obtained using three-dimensional inversion recovery FLASH after 15±5 min. The MRI features were evaluated, including valvular pathologies on cine MRI and contrast enhancement on the walls of the cardiac chambers, major thoracic vasculature, and paravalvular tissue, attributable to endothelial extension of inflammation on contrast-enhanced images. RESULTS: Fourteen valvular vegetations were detected in eleven patients on cardiac MRI. It was not possible to depict valvular vegetations in five patients. Vegetations were detected on the aortic valve (n=7), mitral valve (n=3), tricuspid and pulmonary valves (n=1). Delayed contrast enhancement attributable to extension of inflammation was observed on the aortic wall and aortic root (n=11), paravalvular tissue (n=4), mitral valve (n=2), walls of the cardiac chambers (n=6), interventricular septum (n=3), and wall of the pulmonary artery and superior mesenteric artery (n=1). CONCLUSION: Valvular vegetation features of IE can be detected by MRI. Moreover, in the absence of vegetations, detection of delayed enhancement representing endothelial inflammation of the cardiovascular structures can contribute to the diagnosis and treatment planning of IE.
PURPOSE: We aimed to evaluate the utility of cardiac magnetic resonance imaging (MRI) for the diagnosis of infective endocarditis (IE). METHODS: Sixteen patients with a preliminary diagnosis of IE (10 women and six men; age range, 4-66 years) were referred for cardiac MRI. MRI sequences were as follows: echo-planar cine true fast imaging with steady-state precession (true-FISP), dark-blood fast spin echo T1-weighted imaging, T2-weighted imaging, dark-blood half-Fourier single shot turbo spin echo (HASTE), and early contrast-enhanced first-pass fast low-angle shot (FLASH). Delayed contrast-enhanced images were obtained using three-dimensional inversion recovery FLASH after 15±5 min. The MRI features were evaluated, including valvular pathologies on cine MRI and contrast enhancement on the walls of the cardiac chambers, major thoracic vasculature, and paravalvular tissue, attributable to endothelial extension of inflammation on contrast-enhanced images. RESULTS: Fourteen valvular vegetations were detected in eleven patients on cardiac MRI. It was not possible to depict valvular vegetations in five patients. Vegetations were detected on the aortic valve (n=7), mitral valve (n=3), tricuspid and pulmonary valves (n=1). Delayed contrast enhancement attributable to extension of inflammation was observed on the aortic wall and aortic root (n=11), paravalvular tissue (n=4), mitral valve (n=2), walls of the cardiac chambers (n=6), interventricular septum (n=3), and wall of the pulmonary artery and superior mesenteric artery (n=1). CONCLUSION: Valvular vegetation features of IE can be detected by MRI. Moreover, in the absence of vegetations, detection of delayed enhancement representing endothelial inflammation of the cardiovascular structures can contribute to the diagnosis and treatment planning of IE.
Authors: Ignasi Anguera; Jose M Miro; Isidre Vilacosta; Benito Almirante; Manuel Anguita; Patricia Muñoz; Jose Alberto San Roman; Aristides de Alarcon; Tomas Ripoll; Enrique Navas; Carlos Gonzalez-Juanatey; Christopher H Cabell; Cristina Sarria; Ignacio Garcia-Bolao; M Carmen Fariñas; Ruben Leta; Gabriel Rufi; Francisco Miralles; Carles Pare; Artur Evangelista; Vance G Fowler; Carlos A Mestres; Elisa de Lazzari; Joan R Guma Journal: Eur Heart J Date: 2004-11-30 Impact factor: 29.983
Authors: A S Bayer; A F Bolger; K A Taubert; W Wilson; J Steckelberg; A W Karchmer; M Levison; H F Chambers; A S Dajani; M H Gewitz; J W Newburger; M A Gerber; S T Shulman; T J Pallasch; T W Gage; P Ferrieri Journal: Circulation Date: 1998 Dec 22-29 Impact factor: 29.690
Authors: Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Ann F Bolger; Matthew E Levison; Patricia Ferrieri; Michael A Gerber; Lloyd Y Tani; Michael H Gewitz; David C Tong; James M Steckelberg; Robert S Baltimore; Stanford T Shulman; Jane C Burns; Donald A Falace; Jane W Newburger; Thomas J Pallasch; Masato Takahashi; Kathryn A Taubert Journal: Circulation Date: 2005-06-14 Impact factor: 29.690
Authors: R Choussat; D Thomas; R Isnard; P L Michel; B Iung; G Hanania; P Mathieu; M David; T du Roy de Chaumaray; G De Gevigney; H Le Breton; Y Logeais; E Pierre-Justin; C de Riberolles; Y Morvan; N Bischoff Journal: Eur Heart J Date: 1999-02 Impact factor: 29.983
Authors: Pablo Maria Alberto Pomerantzeff; Carlos Manuel de Almeida Brandão; João Marcelo Albuquerque; José Lima Oliveira; Altamiro Ribeiro Dias; Alfredo José Mansur; Max Grinberg; Sérgio Almeida de Oliveira Journal: J Card Surg Date: 2005 Jul-Aug Impact factor: 1.620
Authors: Neil K Mehta; Jiwon Kim; Jonathan Y Siden; Sara Rodriguez-Diego; Javid Alakbarli; Antonino Di Franco; Jonathan W Weinsaft Journal: J Thorac Dis Date: 2017-04 Impact factor: 2.895
Authors: Kathleen M Capaccione; Sophia Huang; Jay S Leb; Belinda D'souza; Jonathan Goldstein; Mary M Salvatore Journal: Radiol Res Pract Date: 2022-06-16